FDA grants AstraZeneca immune drug orphan status
April 15, 2015Sales and Marketing AstraZeneca, FDA, Iressa, MEDI4736, MedImmune, NSCLC, US, gefitinib, non-small cell lung cancer, tremelimumab
The US Food and Drug Administration has granted orphan drug designation to AstraZeneca’s anti-CTLA-4 monoclonal antibody tremelimumab for the treatment …
AZ and Takeda diabetes drugs get FDA safety update
April 15, 2015Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin
An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …
J&J strong pharma sales can’t offset Q1 losses
April 15, 2015Sales and Marketing J&J, JJ, Q1, Waldenström's macroglobulinemia, Waldenström’s Macroglobulinemia, Zytiga, abiraterone acetate, financials, ibrutinib, imbruvica
Johnson & Johnson’s pharma division achieved worldwide sales of $7.7 billion in the first quarter of this year – but …
Vetter confirms new managing director
April 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oliver Albrecht, Vetter
German contract development and manufacturing organisation Vetter has appointed Oliver Albrecht as a managing director. Albrecht replaces Max Horn in …
World Health Organisation calls for full trial transparency
April 14, 2015Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency
The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …
IBM partners with J&J, Apple and Medtronics ‘to transform healthcare’
April 14, 2015Sales and Marketing Apple, J&J, JJ, ibm, medtronics
IT firm IBM has teamed up with pharma giants and tech companies to expand its presence in the health and …
AstraZeneca partners with PatientsLikeMe
April 14, 2015Sales and Marketing AstraZeneca, Lupus, PatientsLikeMe, Roche, diabetes, oncology, respiratory disease
AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …
Sanofi rules out Toujeo discount in diabetes
April 14, 2015Sales and Marketing 100 U/mL, Boehringer, Lantus, insulin glargine [rDNA origin] injection, lilly, toujeo
Sanofi has revealed that it will not discount its new insulin Toujeo more than its current blockbuster Lantus, despite lacking …
US drug spend soars to all-time high in 2014
April 14, 2015Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing
The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …
Manufacturing woes hit Baxter again
April 14, 2015Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group
Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter. The news has …
Ashfield Healthcare names new UK managing director
April 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield, colin watson
Ashfield Healthcare has appointed Colin Watson as its managing director for the UK, taking over from Enda Scott who has …
Cancer Research Technology and Medivir to develop new class of cancer drugs
April 13, 2015Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology
Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …
Most anticipated health wearable lands shortly
April 13, 2015Medical Communications, Sales and Marketing Apple, digital, research kit, smartwatch, watch, wearable, wearables
Consumers can order Apple’s eagerly anticipated watch now as the industry waits to see just what impact it could have …
Novartis to highlight Gilenya data at neurology congress
April 13, 2015Sales and Marketing American Academy of Neurology, Novartis, fingolimod, gilenya
Novartis will be highlighting data for its multiple sclerosis drug Gilenya at this year’s American Academy of Neurology (AAN) annual …
Drug development showcasing at AACR conference
April 13, 2015Research and Development, Sales and Marketing American Association of Cancer Research, AstraZeneca, Bayer, Genentech, Novartis, aacr
This month’s American Association of Cancer Research conference is set to showcase the latest studies in oncology. Roche’s biotech subsidiary …
AstraZeneca diabetes drug could ‘significantly’ increase mortality
April 13, 2015Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin
AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …
E-clinical: the rise of new health technologies
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, NHS, apps, digital, eHealth, eyeforpharma, kelsey, pharma, wearables
In the UK the NHS is generally considered to be traditionally resistant to new technology, but it has been forced …
Bioinformatics pioneer joins 23andMe from Genentech
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Genentech, Robert Gentleman
California-based personal genetics firm 23andMe has appointed Robert Gentleman to be its vice president of computational biology. The company is …
Novo Nordisk opens insulin plant in Russia
April 10, 2015Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill
Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …
Pfizer launches cardiovascular research competition
April 10, 2015Research and Development, Sales and Marketing Amgen, Astellas, LDL, PCSK9, Pfizer, bococizumab, inhibitors
Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
